Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-307947
Filing Date
2021-10-26
Accepted
2021-10-26 16:06:20
Documents
13
Period of Report
2021-08-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d242143d8ka.htm   iXBRL 8-K/A 27786
  Complete submission text file 0001193125-21-307947.txt   197701

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210806.xsd EX-101.SCH 3965
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210806_def.xml EX-101.DEF 14668
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210806_lab.xml EX-101.LAB 24362
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210806_pre.xml EX-101.PRE 15766
6 EXTRACTED XBRL INSTANCE DOCUMENT d242143d8ka_htm.xml XML 7046
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39801 | Film No.: 211348420
SIC: 2834 Pharmaceutical Preparations